2019
DOI: 10.1093/nc/niz003
|View full text |Cite
|
Sign up to set email alerts
|

Psychedelics as a treatment for disorders of consciousness

Abstract: Based on its ability to increase brain complexity, a seemingly reliable index of conscious level, we propose testing the capacity of the classic psychedelic, psilocybin, to increase conscious awareness in patients with disorders of consciousness. We also confront the considerable ethical and practical challenges this proposal must address, if this hypothesis is to be directly assessed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
81
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(81 citation statements)
references
References 65 publications
(100 reference statements)
0
81
0
Order By: Relevance
“…6D). Prior studies have reported global hyperconnectivity of fMRI signals in schizophrenic patients (34), as well as shared phenomenology between schizophrenic symptoms and ketamine's dissociative/ psychoactive effects (30,32). All participants receiving ketamine reported having dreams, and 8 of 12 participants in our study could recall their hallucinations (e.g., flying on a cloud, weird smells, taking an elevator, and thick mist) after recovery from anesthesia.…”
Section: Distinct Spatiotemporal Characteristics During Behavioral Unmentioning
confidence: 64%
See 1 more Smart Citation
“…6D). Prior studies have reported global hyperconnectivity of fMRI signals in schizophrenic patients (34), as well as shared phenomenology between schizophrenic symptoms and ketamine's dissociative/ psychoactive effects (30,32). All participants receiving ketamine reported having dreams, and 8 of 12 participants in our study could recall their hallucinations (e.g., flying on a cloud, weird smells, taking an elevator, and thick mist) after recovery from anesthesia.…”
Section: Distinct Spatiotemporal Characteristics During Behavioral Unmentioning
confidence: 64%
“…We assessed whether the suppression of DMN+ and DAT+ is specific to the reduced level of responsiveness as opposed to disorders of cognitive function in general. Another motivation was to further understand the ketamine-specific alterations in the CAP occurrence rates, as altered states of consciousness induced by ketamine are often associated with psychoactive effects and unique brain dynamics (30)(31)(32). Using the same method applied in the task dataset (i.e., maximal similarity to the predefined CAP centroids from the main cohort), we identified eight comparable CAPs in the psychiatric cohort ( Fig.…”
Section: Stimulus Modulations Of Caps and Control Analysis In Psychiamentioning
confidence: 99%
“…Such a framework could potentially make individualised predictions of the action of serotonergic psychedelics on specific individuals, aiding patient stratification and treatment customization. 2 Finally, it is worth noting that all our analyses here are based on the univariate statistics of individual brain regions, not including any correlation or information flow between them. However, it is known that some high-level subjective effects of psychedelics (such as complex imagery 7 and ego dissolution 28 ) are related to network, as opposed to single region, dynamics.…”
Section: Current Limitations and Future Researchmentioning
confidence: 99%
“…Psychedelic drugs provide a privileged opportunity to study the mind-brain relationship, and promise to revolutionise some of our current mental health treatments. [1][2][3] However, while some aspects of the neurochemical action of psychedelics at the neuronal and sub-neuronal level are well known, 4,5 our current understanding of their action at the whole-brain level, is still very limited. A deeper understanding of the mechanisms that trigger the changes in conscious experience produced by psychedelics would greatly advance our knowledge of human consciousness, and medical development of psychedelics.…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, the positive therapeutic effects seem to scale with "peak" or mystical experience in the psychedelic state (Roseman, Nutt, & Carhart-Harris, 2018). Psychedelics have been shown to be effective in treating depression (Lyons & Carhart-Harris, 2018;Palhano-Fontes et al, 2019), obsessivecompulsive disorder (Moreno, Wiegand, Taitano, & Delgado, 2006), end of life existential distress (Griffiths et al, 2016), and have even been proposed as a potential treatment for disorders of consciousness such as the vegetative state and the minimally conscious state (Scott & Carhart-Harris, 2019). Carhart-Harris interprets the therapeutic effects as a result of "relaxing" high-level beliefs, allowing for a revision of pathological beliefs that have become overly dominant and resistant to revision, coined the "TIghtened BEliefs in Response to uncertainty" (TIBER) model (Carhart-Harris, 2019).…”
Section: Psychedelic Therapymentioning
confidence: 99%